Dublin, Jan. 19, 2017 -- Research and Markets has announced the addition of the "Global Drug Delivery Technologies Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
Latest Market Trends
- Growing demand for Drug Delivery Devices in Emerging Markets
- Advancing delivery of biopharmaceuticals
- New biomaterials for medical devices
- Growth Opportunities/Investment Opportunities
The Global Drug Delivery Technologies Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $2,222 billion by 2025.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.
This industry report analyzes the global markets for Drug Delivery Technologies across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Key Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Growing demand for Drug Delivery Devices in Emerging Markets
3.1.2 Advancing delivery of biopharmaceuticals
3.1.3 New biomaterials for medical devices
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
4 Drug Delivery Technologies Market, By Route of Administration
4.1 Injectable Drug Delivery
4.2 Implantable Drug Delivery
4.3 Oral Drug Delivery
4.4 Ocular Drug Delivery
4.5 Pulmonary Drug Delivery
4.6 Transmucosal Drug Delivery
4.7 Nasal Drug Delivery
4.8 Topical Drug Delivery
5 Drug Delivery Technologies Market, By End User
5.1 Hospitals
5.2 Home care settings
5.3 Clinics
5.4 Diagnostic Centres
5.5 Other End Users
6 Drug Delivery Technologies Market, By Geography
7 Leading Companies
7.1 3M Company
7.2 Merck & Co., Inc.
7.3 Pfizer Inc
7.4 Johnson & Johnson
7.5 Nektar Therapeutics Ltd.
7.6 Bayer AG
7.7 pSivida Corp
7.8 Sanofi
7.9 Generex Biotechnology
7.10 Abbott Medical Optics
7.11 Novartis AG
7.12 Flamel Technologies Inc.
7.13 Vectura Group Plc.
7.14 Antares Pharma
7.15 Skye Pharma Plc.
For more information about this report visit http://www.researchandmarkets.com/research/rtb78p/global_drug
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Britain Courts Anthropic Amid US Defense Department Dispute
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 



